Inventor · disambiguated record
Charles H. Hannum
Also filed as: HANNUM CHARLES H
6 granted patents·4 pending applications·424 citations·filing 1990–2024
85Inventor score
Files withAMGEN INC2I2 PHARMACEUTICALS INC2SCHERING CORP2SEA LANE BIOTECHNOLOGIES LLC2REVOPSIS THERAPEUTICS INC1
Top patents by PatentIndex Score
10 records- 0195US5075222AInterleukin-1 inhibitorsSYNERGEN INC·Filed 1990·Granted Dec 24, 1991·277 cites·31 claims
- 0290US6599873B1Interleukin-1 inhibitors, compositions, and methods of treatmentAMGEN INC·Filed 1995·Granted Jul 29, 2003·97 cites·296 claims
- 0378US2025127793A1Conjugates of surrogate light chain constructsREVOPSIS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0468US6858409B1Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitorsAMGEN INC·Filed 1995·Granted Feb 22, 2005·35 cites·105 claims
- 0553US2019127482A1Conjugates of surrogate light chain constructsI2 PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0649US7534867B1Purified mammalian Flt3 ligands; agonists; antagonistsSCHERING CORP·Filed 1995·Granted May 19, 2009·12 cites·3 claims
- 0749US2015011736A1Binding molecule conjugatesSEA LANE BIOTECHNOLOGIES LLC·Filed 2013·Application pending·0 cites
- 0844US9975956B2Surrogate binding proteins which bind DR4 and/or DR5I2 PHARMACEUTICALS INC·Filed 2012·Granted May 22, 2018·0 cites·15 claims
- 0944US2016354486A1Binding molecule conjugatesSEA LANE BIOTECHNOLOGIES LLC·Filed 2015·Application pending·0 cites
- 1035US7537932B1Antibodies that bind purified mammalian FLT3 ligandsSCHERING CORP·Filed 1995·Granted May 26, 2009·3 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Charles H. Hannum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →